SG188283A1 - Pharmaceutical composition for treating insomnia and preparation method thereof - Google Patents

Pharmaceutical composition for treating insomnia and preparation method thereof Download PDF

Info

Publication number: SG188283A1
Authority: SG; Singapore
Prior art keywords: pharmaceutical composition; composition according; extract; extracts; ratios
Prior art date: 2010-08-30

Application number

SG2013013719A

Other languages

English (en)

Inventor

Yiling Wu

Original Assignee

Hebei Yiling Medicine Res Inst Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-08-30

Filing date

2010-08-30

Publication date

2013-04-30

2010-08-30 Application filed by Hebei Yiling Medicine Res Inst Co Ltd filed Critical Hebei Yiling Medicine Res Inst Co Ltd

2013-04-30 Publication of SG188283A1 publication Critical patent/SG188283A1/en

Links

239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 92
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 30
206010022437 insomnia Diseases 0.000 title claims abstract description 30
238000002360 preparation method Methods 0.000 title abstract description 50
239000000284 extract Substances 0.000 claims abstract description 98
241000628997 Flos Species 0.000 claims abstract description 94
210000000582 semen Anatomy 0.000 claims abstract description 55
241000222336 Ganoderma Species 0.000 claims abstract description 48
241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 48
206010016256 fatigue Diseases 0.000 claims abstract description 8
208000000044 Amnesia Diseases 0.000 claims abstract description 7
208000031091 Amnestic disease Diseases 0.000 claims abstract description 7
230000006986 amnesia Effects 0.000 claims abstract description 7
208000002173 dizziness Diseases 0.000 claims abstract description 7
208000024891 symptom Diseases 0.000 claims abstract description 6
210000003127 knee Anatomy 0.000 claims abstract description 5
239000003814 drug Substances 0.000 claims description 115
229940079593 drug Drugs 0.000 claims description 108
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 96
239000000843 powder Substances 0.000 claims description 46
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
239000006286 aqueous extract Substances 0.000 claims description 29
238000000034 method Methods 0.000 claims description 23
239000003826 tablet Substances 0.000 claims description 16
230000002829 reductive effect Effects 0.000 claims description 15
239000006187 pill Substances 0.000 claims description 14
238000010992 reflux Methods 0.000 claims description 13
238000009835 boiling Methods 0.000 claims description 9
239000002775 capsule Substances 0.000 claims description 9
239000007924 injection Substances 0.000 claims description 9
238000002347 injection Methods 0.000 claims description 9
230000000147 hypnotic effect Effects 0.000 claims description 8
-1 oral solution Substances 0.000 claims description 8
229940100688 oral solution Drugs 0.000 claims description 8
239000007901 soft capsule Substances 0.000 claims description 8
239000000829 suppository Substances 0.000 claims description 8
239000006188 syrup Substances 0.000 claims description 8
235000020357 syrup Nutrition 0.000 claims description 8
229940098465 tincture Drugs 0.000 claims description 8
206010039897 Sedation Diseases 0.000 claims description 7
239000002552 dosage form Substances 0.000 claims description 7
239000000499 gel Substances 0.000 claims description 7
230000036280 sedation Effects 0.000 claims description 7
239000007921 spray Substances 0.000 claims description 7
239000004480 active ingredient Substances 0.000 claims description 6
239000002904 solvent Substances 0.000 claims description 5
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
208000002193 Pain Diseases 0.000 claims description 4
230000002929 anti-fatigue Effects 0.000 claims description 4
239000000706 filtrate Substances 0.000 claims description 4
230000015654 memory Effects 0.000 claims description 4
230000036407 pain Effects 0.000 claims description 4
239000002398 materia medica Substances 0.000 claims description 3
239000000203 mixture Substances 0.000 claims description 3
230000001737 promoting effect Effects 0.000 claims description 3
239000001569 carbon dioxide Substances 0.000 claims description 2
229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
239000000243 solution Substances 0.000 claims description 2
241000699670 Mus sp. Species 0.000 description 49
230000000694 effects Effects 0.000 description 17
238000002474 experimental method Methods 0.000 description 17
CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 14
229960002336 estazolam Drugs 0.000 description 14
230000006742 locomotor activity Effects 0.000 description 12
238000005516 engineering process Methods 0.000 description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
238000007796 conventional method Methods 0.000 description 9
238000007639 printing Methods 0.000 description 9
239000002994 raw material Substances 0.000 description 9
230000037396 body weight Effects 0.000 description 8
235000011389 fruit/vegetable juice Nutrition 0.000 description 8
239000000463 material Substances 0.000 description 8
241000196324 Embryophyta Species 0.000 description 7
QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 7
ZRJBHWIHUMBLCN-YQEJDHNASA-N huperzine A Chemical compound N1C(=O)C=CC2=C1C[C@H]1\C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-YQEJDHNASA-N 0.000 description 7
229960002275 pentobarbital sodium Drugs 0.000 description 7
230000036578 sleeping time Effects 0.000 description 7
230000009182 swimming Effects 0.000 description 7
241001107116 Castanospermum australe Species 0.000 description 6
ZRJBHWIHUMBLCN-SEQYCRGISA-N Huperzine A Natural products N1C(=O)C=CC2=C1C[C@H]1/C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-SEQYCRGISA-N 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
ZRJBHWIHUMBLCN-UHFFFAOYSA-N Shuangyiping Natural products N1C(=O)C=CC2=C1CC1C(=CC)C2(N)CC(C)=C1 ZRJBHWIHUMBLCN-UHFFFAOYSA-N 0.000 description 6
235000021279 black bean Nutrition 0.000 description 6
238000001514 detection method Methods 0.000 description 6
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
ZRJBHWIHUMBLCN-BMIGLBTASA-N rac-huperzine A Natural products N1C(=O)C=CC2=C1C[C@@H]1C(=CC)[C@@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-BMIGLBTASA-N 0.000 description 6
FIMXSEMBHGTNKT-UHFFFAOYSA-N Scopine Natural products CN1C2CC(O)CC1C1C2O1 FIMXSEMBHGTNKT-UHFFFAOYSA-N 0.000 description 5
238000010171 animal model Methods 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000035475 disorder Diseases 0.000 description 5
FIMXSEMBHGTNKT-RZVDLVGDSA-N scopine Chemical compound C([C@@H]1N2C)[C@H](O)C[C@@H]2[C@@H]2[C@H]1O2 FIMXSEMBHGTNKT-RZVDLVGDSA-N 0.000 description 5
239000011734 sodium Substances 0.000 description 5
229920002472 Starch Polymers 0.000 description 4
230000006870 function Effects 0.000 description 4
238000003304 gavage Methods 0.000 description 4
239000008187 granular material Substances 0.000 description 4
239000007928 intraperitoneal injection Substances 0.000 description 4
238000002156 mixing Methods 0.000 description 4
238000004513 sizing Methods 0.000 description 4
208000019116 sleep disease Diseases 0.000 description 4
208000020685 sleep-wake disease Diseases 0.000 description 4
238000005507 spraying Methods 0.000 description 4
239000008107 starch Substances 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
238000012360 testing method Methods 0.000 description 4
238000012549 training Methods 0.000 description 4
101100289061 Drosophila melanogaster lili gene Proteins 0.000 description 3
238000012449 Kunming mouse Methods 0.000 description 3
229920000168 Microcrystalline cellulose Polymers 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
230000002354 daily effect Effects 0.000 description 3
239000003651 drinking water Substances 0.000 description 3
235000020188 drinking water Nutrition 0.000 description 3
229940000406 drug candidate Drugs 0.000 description 3
239000000686 essence Substances 0.000 description 3
239000003777 experimental drug Substances 0.000 description 3
235000003599 food sweetener Nutrition 0.000 description 3
238000005286 illumination Methods 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
235000019359 magnesium stearate Nutrition 0.000 description 3
239000008108 microcrystalline cellulose Substances 0.000 description 3
235000019813 microcrystalline cellulose Nutrition 0.000 description 3
229940016286 microcrystalline cellulose Drugs 0.000 description 3
230000000144 pharmacologic effect Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
229960004499 scopolamine hydrobromide Drugs 0.000 description 3
WTGQALLALWYDJH-MOUKNHLCSA-N scopolamine hydrobromide (anhydrous) Chemical compound Br.C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 WTGQALLALWYDJH-MOUKNHLCSA-N 0.000 description 3
230000001624 sedative effect Effects 0.000 description 3
239000002689 soil Substances 0.000 description 3
238000007619 statistical method Methods 0.000 description 3
238000010025 steaming Methods 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
239000003765 sweetening agent Substances 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
230000002618 waking effect Effects 0.000 description 3
MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
206010010071 Coma Diseases 0.000 description 2
241000234280 Liliaceae Species 0.000 description 2
229920000881 Modified starch Polymers 0.000 description 2
208000007443 Neurasthenia Diseases 0.000 description 2
206010033557 Palpitations Diseases 0.000 description 2
241000222341 Polyporaceae Species 0.000 description 2
241001558929 Sclerotium <basidiomycota> Species 0.000 description 2
208000010340 Sleep Deprivation Diseases 0.000 description 2
244000273928 Zingiber officinale Species 0.000 description 2
235000006886 Zingiber officinale Nutrition 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
239000002249 anxiolytic agent Substances 0.000 description 2
230000000949 anxiolytic effect Effects 0.000 description 2
206010003549 asthenia Diseases 0.000 description 2
229940049706 benzodiazepine Drugs 0.000 description 2
150000001557 benzodiazepines Chemical class 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000007884 disintegrant Substances 0.000 description 2
238000007908 dry granulation Methods 0.000 description 2
235000013399 edible fruits Nutrition 0.000 description 2
238000000605 extraction Methods 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
235000008397 ginger Nutrition 0.000 description 2
238000005469 granulation Methods 0.000 description 2
230000003179 granulation Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
238000010172 mouse model Methods 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000003014 reinforcing effect Effects 0.000 description 2
230000028527 righting reflex Effects 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000000375 suspending agent Substances 0.000 description 2
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
229940100578 Acetylcholinesterase inhibitor Drugs 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
240000007185 Albizia julibrissin Species 0.000 description 1
235000011468 Albizia julibrissin Nutrition 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000605445 Anemarrhena asphodeloides Species 0.000 description 1
108010011485 Aspartame Proteins 0.000 description 1
241000208838 Asteraceae Species 0.000 description 1
241000587155 Athene Species 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
241000282461 Canis lupus Species 0.000 description 1
241000131317 Capitulum Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
244000189548 Chrysanthemum x morifolium Species 0.000 description 1
241000737241 Cocos Species 0.000 description 1
UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
206010013754 Drug withdrawal syndrome Diseases 0.000 description 1
241000220485 Fabaceae Species 0.000 description 1
241001289529 Fallopia multiflora Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
240000008397 Ganoderma lucidum Species 0.000 description 1
235000001637 Ganoderma lucidum Nutrition 0.000 description 1
241001489091 Ganoderma sinense Species 0.000 description 1
MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
101000579423 Homo sapiens Regulator of nonsense transcripts 1 Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241000207923 Lamiaceae Species 0.000 description 1
240000008058 Lilium brownii Species 0.000 description 1
235000015982 Lilium brownii Nutrition 0.000 description 1
244000210789 Lilium lancifolium Species 0.000 description 1
235000002156 Lilium lancifolium Nutrition 0.000 description 1
241001634090 Lilium pumilum Species 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
208000026139 Memory disease Diseases 0.000 description 1
206010027590 Middle insomnia Diseases 0.000 description 1
241000218231 Moraceae Species 0.000 description 1
240000000249 Morus alba Species 0.000 description 1
235000008708 Morus alba Nutrition 0.000 description 1
RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 1
208000000114 Pain Threshold Diseases 0.000 description 1
244000046052 Phaseolus vulgaris Species 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
241000700159 Rattus Species 0.000 description 1
102100028287 Regulator of nonsense transcripts 1 Human genes 0.000 description 1
241000219100 Rhamnaceae Species 0.000 description 1
206010039203 Road traffic accident Diseases 0.000 description 1
241000304195 Salvia miltiorrhiza Species 0.000 description 1
235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
241000612118 Samolus valerandi Species 0.000 description 1
241001474728 Satyrodes eurydice Species 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
244000126002 Ziziphus vulgaris Species 0.000 description 1
235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000000605 aspartame Substances 0.000 description 1
235000010357 aspartame Nutrition 0.000 description 1
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
229960003438 aspartame Drugs 0.000 description 1
229960002233 benzalkonium bromide Drugs 0.000 description 1
KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
229960002152 chlorhexidine acetate Drugs 0.000 description 1
239000000544 cholinesterase inhibitor Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000009194 climbing Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000009837 dry grinding Methods 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
229960003720 enoxolone Drugs 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
229940044949 eucalyptus oil Drugs 0.000 description 1
239000010642 eucalyptus oil Substances 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
230000003137 locomotive effect Effects 0.000 description 1
229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000001543 one-way ANOVA Methods 0.000 description 1
230000037040 pain threshold Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000003672 processing method Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
230000003236 psychic effect Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
229940085605 saccharin sodium Drugs 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000004576 sand Substances 0.000 description 1
239000000932 sedative agent Substances 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
230000004622 sleep time Effects 0.000 description 1
239000002002 slurry Substances 0.000 description 1
235000015424 sodium Nutrition 0.000 description 1
WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
239000004299 sodium benzoate Substances 0.000 description 1
235000010234 sodium benzoate Nutrition 0.000 description 1
235000002639 sodium chloride Nutrition 0.000 description 1
229960001462 sodium cyclamate Drugs 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
229960004793 sucrose Drugs 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
238000012353 t test Methods 0.000 description 1
231100000820 toxicity test Toxicity 0.000 description 1
230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
239000002023 wood Substances 0.000 description 1
230000037303 wrinkles Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Alternative & Traditional Medicine (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Medicines Containing Plant Substances (AREA)

SG2013013719A 2010-08-30 2010-08-30 Pharmaceutical composition for treating insomnia and preparation method thereof SG188283A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/CN2010/076472 WO2012027882A1 (zh)	2010-08-30	2010-08-30	治疗失眠的药物组合物及其制备方法

Publications (1)

Publication Number	Publication Date
SG188283A1 true SG188283A1 (en)	2013-04-30

Family

ID=45772071

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG2013013719A SG188283A1 (en)	2010-08-30	2010-08-30	Pharmaceutical composition for treating insomnia and preparation method thereof

Country Status (5)

Country	Link
KR (1)	KR101457315B1 (ko)
MY (1)	MY170194A (ko)
RU (1)	RU2548756C2 (ko)
SG (1)	SG188283A1 (ko)
WO (1)	WO2012027882A1 (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102895345A (zh) *	2012-10-22	2013-01-30	重庆希尔安药业有限公司	治疗失眠的药物组合物
CN103169787B (zh) *	2012-11-30	2014-11-26	云南白药天颐茶品有限公司	一种具有提高睡眠质量延长深度睡眠时间的组合物及其应用
CN103127297A (zh) *	2013-03-23	2013-06-05	李艳	一种治疗恐惧性神经症的中药组合物及其制备方法
KR101690175B1 (ko)	2013-07-02	2016-12-27	경희대학교 산학협력단	고본 추출물을 유효성분으로 포함하는 불면증의 예방 또는 치료용 약학적 조성물
CN103599209A (zh) *	2013-11-28	2014-02-26	佘坤	一种治疗神经衰弱的中药
CN104013691A (zh) *	2014-06-20	2014-09-03	苏州法莫生物技术有限公司	一种改善睡眠作用的颗粒剂
CN104013724A (zh) *	2014-06-20	2014-09-03	苏州法莫生物技术有限公司	一种改善睡眠的中药组合物
CN104013690A (zh) *	2014-06-20	2014-09-03	苏州法莫生物技术有限公司	改善睡眠的中药
CN104013694A (zh) *	2014-06-20	2014-09-03	苏州法莫生物技术有限公司	一种改善睡眠的中药组方
CN104056230B (zh) *	2014-06-26	2017-06-23	余明	一种治疗心脾两虚型失眠的中药组合物
CN104873609A (zh) *	2015-04-30	2015-09-02	肖祥宇	一种治疗失眠的药物及其制备方法
CN105232670A (zh) *	2015-11-11	2016-01-13	王书汉	一种枣树叶有效成分的提取方法及所得产品
KR101685631B1 (ko) *	2016-06-10	2016-12-13	순천대학교 산학협력단	숙면용 한방 방향제
KR20180098459A (ko) *	2017-02-24	2018-09-04	한국 한의학 연구원	백합 비늘줄기 추출물을 포함하는 인지장애의 예방 또는 치료용 약학 조성물
CN107095985A (zh) *	2017-06-13	2017-08-29	邵竹蕾	一种用于治疗产后失眠征的中药冲剂及制备方法
CN108310330A (zh) *	2018-05-03	2018-07-24	郭亚方	一种治疗失眠的内服中药组合物
KR20200097460A (ko)	2019-02-08	2020-08-19	장영희	메타아르세나이트 염을 포함하는 불면증에 유용한 조성물
CN114081171A (zh) *	2020-08-09	2022-02-25	辽宁医学诊疗科技研发中心有限公司	一种具有辅助改善睡眠作用的功能性食品组合物
CN112568293A (zh) *	2020-12-23	2021-03-30	北京可利可徕科技有限公司	一种调节睡眠障碍的乳饮料及其制备方法
CN112807398A (zh) *	2021-01-21	2021-05-18	中国人民解放军军事科学院军事医学研究院	一种具有滋阴清热，养血安神功效的中药组合物
KR102590559B1 (ko)	2021-01-27	2023-10-18	에이치엠오건강드림영농조합법인	불면증 및 수면장애 질환의 예방, 개선 또는 치료용에 있어서 굼벵이 추출물을 유효성분으로 포함하는 조성물
CN113509438A (zh) *	2021-04-28	2021-10-19	浙江工业大学	一种用于治疗失眠的西红花药物组合乳剂及其制备与应用
KR20240086230A (ko) *	2022-12-09	2024-06-18	가톨릭관동대학교산학협력단	복령 추출물을 포함하는 불면증 예방 또는 개선용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3686063B2 (ja) *	2002-03-12	2005-08-24	末人山上	睡眠障害の改善作用を有する健康補助食品
CN100553669C (zh) *	2006-03-24	2009-10-28	郭云华	一种强身益智保健品及其制备方法
CN100551429C (zh) *	2007-01-31	2009-10-21	张金桦	一种补益肝肾、健脑益智的药物及其制备方法
CN101301450A (zh) *	2008-06-25	2008-11-12	崔凤玉	一种治疗失眠症的药物
CN101524513B (zh) *	2009-04-07	2012-01-04	秭归县兴盛贸易有限责任公司	一种保健枕药芯
CN101543612B (zh) *	2009-05-12	2012-07-04	王秋贤	治疗恶性淋巴瘤的中药
CN101574499A (zh) *	2009-06-05	2009-11-11	李振爽	安神宁心胶囊

2010
- 2010-08-30 KR KR1020137007571A patent/KR101457315B1/ko active IP Right Grant
- 2010-08-30 WO PCT/CN2010/076472 patent/WO2012027882A1/zh active Application Filing
- 2010-08-30 MY MYPI2013000612A patent/MY170194A/en unknown
- 2010-08-30 RU RU2013112349/15A patent/RU2548756C2/ru active
- 2010-08-30 SG SG2013013719A patent/SG188283A1/en unknown

Also Published As

Publication number	Publication date
WO2012027882A1 (zh)	2012-03-08
KR20130062347A (ko)	2013-06-12
RU2548756C2 (ru)	2015-04-20
KR101457315B1 (ko)	2014-11-20
RU2013112349A (ru)	2014-10-10
MY170194A (en)	2019-07-09

Publication	Publication Date	Title
SG188283A1 (en)	2013-04-30	Pharmaceutical composition for treating insomnia and preparation method thereof
CN107006856A (zh)	2017-08-04	一种增强耐力、提高抗缺氧耐受力营养剂及其制备方法
CN101244208B (zh)	2010-05-12	一种治疗抑郁症及焦虑症的中药制剂的制备方法
CN102846879B (zh)	2014-01-29	一种降血脂的组合物
CN108837101B (zh)	2021-07-27	一种治疗失眠的中药膏及制备方法
CN116370556A (zh)	2023-07-04	一种活血祛瘀、益气安神的中药组合物及其制备方法
CN107890528B (zh)	2021-02-05	一种治疗高尿酸血症的中药组合物及其制备方法
CN102895387B (zh)	2014-06-18	一种温补肾阳的药物组合物、制剂及其制备方法
CN105831751B (zh)	2020-01-03	补气健脑的中药保健组合物、制备方法及其使用方法
CN103735871A (zh)	2014-04-23	一种治疗神经衰弱的中药组合物及其制备方法
CN103385931A (zh)	2013-11-13	一种降血糖的药物组合物
CN102846720B (zh)	2013-11-13	一种降血脂、提高缺氧耐受力的组合物
CN104840773A (zh)	2015-08-19	治疗椎动脉型颈椎病的中药组合物及制法
CN104547309A (zh)	2015-04-29	一种祛黄褐斑的中药组合物及其制备方法与应用
CN110201056A (zh)	2019-09-06	一种中药组合物及其制剂、制备方法和应用
CN108210588A (zh)	2018-06-29	一种具有镇静安神作用的药物组合物及制备方法
CN114848724B (zh)	2023-08-18	一种治疗偏头痛的中药组合物及其制备方法
CN108721477B (zh)	2021-03-23	一种用于治疗脏器痉挛的药物制剂及其制备方法
CN106110089A (zh)	2016-11-16	一种治疗焦虑、失眠的中药组合物及其制备方法
CN105250749A (zh)	2016-01-20	一种治疗甲状腺腺瘤的中药及其制备方法
CN104623319A (zh)	2015-05-20	一种治疗心虚胆怯型心律失常的中药及制备方法
CN104547695B (zh)	2019-05-03	一种用于治疗三叉神经痛的药物组合物及其应用
CN117064964A (zh)	2023-11-17	用于减肥的中药组合物
CN103690834A (zh)	2014-04-02	一种降压中药组合物及其制备方法
CN103751283A (zh)	2014-04-30	一种治疗心悸的中药组合物及其制备方法